Skip to main content
. 2016 Aug 13;5(11):1072–1082. doi: 10.1016/j.molmet.2016.08.004

Table 2.

Chemical modification of siINDY improved its pharmacokinetic properties.

siRNA siINDY* (unmodified) siINDY
IC50KD (nM) 0.15 0.56
ImaxKD (%) 92 92
Serum stability (h): t1/2 in 50% mouse serum <2 4
Cytotoxicity (%): Viability of Hepa1c1c7 cells 78 135
Immune stimulation (pg/ml): IFNα release PBMCs 2144 70

ImaxKD: maximal knockdown of mINDY mRNA expression.